Wei Xinkang announced on September 10. Recently, Inner Mongolia Baiyi Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the approval and issuance of the “Drug Registration Certificate” for injectable water-soluble vitamins by the State Drug Administration. According to relevant national policies and regulations, obtaining the “Drug Registration Certificate” this time is considered to have passed the consistency evaluation. At present, the company has begun preparations before listing. Since pharmaceutical products have the characteristics of high technology, high risk, and high added value, the future market sales situation after the drug is put into production may be affected by factors such as changes in the market environment and the development of tenders, etc., and there is uncertainty.

Wei Xinkang announced on September 10. Recently, Inner Mongolia Baiyi Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the approval and issuance of the “Drug Registration Certificate” for injectable water-soluble vitamins by the State Drug Administration. According to relevant national policies and regulations, obtaining the “Drug Registration Certificate” this time is considered to have passed the consistency evaluation. At present, the company has begun preparations before listing. Since pharmaceutical products have the characteristics of high technology, high risk, and high added value, the future market sales situation after the drug is put into production may be affected by factors such as changes in the market environment and the development of tenders, etc., and there is uncertainty.